LG Life Sciences
Pharmaceutical Manufacturing • 
Korea, Republic of • 201-500 Employees
Company overview
| Headquarters | Korea, Republic of |
| Websites | |
| NAICS | 3254 |
| Employees | 201-500 |
| Socials |
Key Contacts at LG Life Sciences
Temam Tahir
Cosmetics Whoo Post Brand Agency Managing Director
Fatıma Demirci
Cosmetics Whoo Post Brand Agency Managing Director
Aileen Beloff
Cosmetics Whoo Post Brand Agency Managing Director
Annie Mmamothethi
Cosmetics Whoo Post Brand Agency Managing Director
Aileen Park
Cosmetics Whoo Post Brand Agency Managing Director
Althea Carvalho
Cosmetics Whoo Post Brand Agency Managing Director
Muhamad Yoga Adam Pratama
Cosmetics Whoo Post Brand Agency Managing Director
Ada Ginting
Cosmetics Whoo Post Brand Agency Managing Director
Lorien Wilson
Cosmetics Whoo Post Brand Agency Managing Director
Hee Dong Park
Director Of Drug Discovery
LG Life Sciences Email Formats
LG Life Sciences uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 54.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 54.7% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 19.2% |
{last name}.{first name}@company.com | doe.john@company.com | 11.3% |
{first name}@company.com | john@company.com | 9.1% |
{first name}{last name}@company.com | johndoe@company.com | 5.7% |
About LG Life Sciences
LG Life Sciences began research in genetic engineering in 1981 and has invested steadily in the life sciences ever since. This effort has already resulted in world-class technology and product capabilities. The company has focused R&D resources and know-how on three areas-pharmaceuticals, animal health and specialty chemicals. LG Life Sciences has developed and commercialized an array of pharmaceuticals over the years. These include interferon in 1989 (Intermax-gamma) and 1992 (Intermax-alpha), hepatitis B vaccine in 1992 (EUVAX B™), human growth hormone in 1993 (EUTROPIN™), degenerative arthritis treatment in 2005 (HYRUAN Plus™), rhFSH (recombinant human follicle stimulating hormone) in 2006 (Follitrope™), and SR-hGH (Sustained Release-human Growth Hormone) in 2007 (Declage™). A company milestone was reached in 2003, when its next-generation quinolone antibiotic (FACTIVE®) was approved by the FDA in the United States. LG Life Sciences has a vision to become a "top-tier life sciences company with world-class new drugs". To this end, LGLS is expanding its strategic alliances and fostering its capabilities to identify candidate drugs for development. Indeed, the company's development of new medicines is accelerating and marketing competencies are being focused on advanced markets. In the future, LG Life Sciences will remain a leader in life sciences and biotechnology-value added areas that are knowledge intensive.
LG Life Sciences revenue & valuation
| Annual revenue | $29,700,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $94,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
LG Life Sciences has 109 employees across 14 departments.
Departments
Number of employees
Funding Data
LG Life Sciences has never raised funding before.
United Arab Emirates
United States
United Kingdom
Italy
Frequently asked questions
4.8
40,000 users
